Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15... Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders. Mehr anzeigen
MIAMI, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Defiance ETFs today launched NVOX, the world's first single-stock leveraged ETF for the pharmaceutical stock Novo Nordisk (NYSE: NVO). As the weight loss...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 3.72 | 3.48804500703 | 106.65 | 110.88 | 104.961 | 4617440 | 106.91106341 | CS |
| 4 | 2.36 | 2.18498287196 | 108.01 | 110.88 | 99.42 | 6075059 | 105.38378376 | CS |
| 12 | -18.86 | -14.5941344889 | 129.23 | 138.2215 | 99.42 | 5110956 | 113.99336887 | CS |
| 26 | -23.53 | -17.572815534 | 133.9 | 148.15 | 99.42 | 4462493 | 123.92117542 | CS |
| 52 | 9.79 | 9.73354543647 | 100.58 | 148.15 | 94.7313 | 4457407 | 122.0451696 | CS |
| 156 | 55.735 | 102.013361398 | 54.635 | 148.15 | 45.755 | 2712983 | 100.20832386 | CS |
| 260 | 82.205 | 291.869341381 | 28.165 | 148.15 | 24.62 | 2112606 | 85.17103491 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
